View Report Details Global Antifungal Therapeutics Market: Trends and Opportunities (2014-2019)
View Report Details Scope of the Report The report titled “Global
Antifungal Therapeutics Market: Trends and Opportunities
(2014- 2019)� provides an in-depth analysis of global antifungal therapeutics market with focus on antifungal drug classes – Polyenes, Azoles, Echinocandins and Allylamines. It provides broad coverage of these classes with detailed analysis of drugs and indications in respective classes. It also assesses the key opportunities and underlying trends in the market and outlines the factors that are and will be driving the growth of the industry in the forecasted period (2014- 19). Further, key players of the industry such as Merck & Co., Inc., Pfizer Inc., Astellas Pharma Inc. and Noble Corporation SCYNEXIS, Inc. are also profiled in the report. Segment Coverage Polyenes Azoles Echinocandin s Allylamines
Company Coverage
Astellas Pharma Inc. SCYNEXIS Inc. Executive Summary Antifungal agents are drugs used for the treatment of fungal infections that can infect almost any part of the body including skin, nails, respiratory tract, urogenital tract and alimentary tract. Treatment of fungal infections currently available in the market can be broadly classified into four major classes of antifungal drugs – Polyenes, Azoles, Allylamines and Echinocandins. Global antifungal market is dominated by systemic antifungal infection. Over
the
past
several years, there
have
been
high
incidences
of
invasive
fungal
infections around the globe. In response to this, various antifungal agents with novel action mechanisms, broader action spectrum and fewer side effects have emerged. Growth within global antifungal therapeutics market is driven by high number of cases of fungal infections, rise in number of immune-compromised aged population and various government initiatives in this field. Some of the restraints to market’s growth are growing resistance to antifungal drugs, limitations with antifungal drugs, presence of generics and government regulations in pharmaceutical industry. Major trends prevailing in the industry includes resistant strains and Candida & Aspergillus causing maximum fungal infections.
growth
in
Global Antifungal Therapeutics Market: Overview Antifungal agents are drugs used for treatment of fungal infections such as athlete’s foot, ringworm,
candidiasis
(thrush),
serious
systemic
infections
such
as
cryptococcal
meningitis, and others ensuring minimal toxicity to the host. Global Antifungal Therapeutics Market Size, 2011-13 (US$ Billions)
2011
2012
2013
Global Antifungal Therapeutics Market Size Forecast, 2014E-19E (US$ Billions)
2014E
2015E
2016E
2017E
2018E
2019E
**Includes systemic antifungal data
• Market size by global antifungal therapeutics market is expected to reach to US$ ……. Billions in the year 2019, from US$…………… billions in 2013 by growing at a CAGR of………%. • Growth in the market is due to …………………………………………….
Global Antifungal Therapeutics Market Share Global Antifungal Drug Class Market Share by Value (2013)
Global Antifungal Drug Type Market Share by Value (2013)
Polyenes xx%
Posaconazo le ee%
Azoles yy%
Fluconazole ff%
Caspofungi n aa%
Micafungin bb% Echinocandi ns zz%
Voriconazol e dd %
Global Antifungal Drug Class Market Share by Volume (2013)
Amphoteric in B cc%
Global Antifungal Drug Type Market Share by Volume (2013) Caspofungi n h%
Polyenes cc% Fluconazole nn%
Echinocandi ns dd%
Azoles ee%
Micafungin kk%
Amphoteric in B ll % Voriconazol e m%
Table of Contents 1. Executive Summary
●
Overview
2. Antifungal Market
●
Azoles Market Sizing (Actual & Forecasted)
1. Fungal Infections
●
Azoles Market Share by Drugs
2.1.1 Fungal Infections: Types
4.3 Echinocandins Antifungal Drugs
3. Antifungal Treatment
4.3.1 Overview
3. Global Antifungal Therapeutics Market Analysis 4.3.3 Echinocandins Market Sizing (Actual & 1. Global Antifungal Therapeutics Market Sizing
Forecasted)
2. Global Antifungal Therapeutics Market Size
4.3.4 Echinocandins Market Share by Drugs
(Actual & Forecasted)
4.4 Allylamines
3. Global Antifungal Therapeutics Market Share
4.4.1 Overview
4. By Geography 5. By Organisms 6. Drug Class by Value 7. Drug Class by Volume 8. Drug Type by Value
5.
Global Antifungal Market Growth Drivers & Challenges 1. Growth Drivers
9. Drug Type by Volume
2. High Incidences of Serious Fungal Infections 4. Global Antifungal Therapeutics Market Segment 5.2 3. Ageing Population Challenges ● by Drug Type Resistance to Antifungal Drugs 4. ● Government Initiatives 1. Polyene Antifungal Drugs Government Regulation 2. Overview
●
3. Polyene Market Sizing (Actual & Forecasted) 4.2 Azoles Antifungal Drugs
Limitations Associated with Drugs Used for Treatments
●
Presence of Generics
Table of Contents 6. Global Antifungal Market Trends
●
Business Overview
1. Growth in Resistant Strains
●
Financial Overview
2. Candida & Aspergillus Causing Maximum Fungal
●
Business Strategies
Infections 8. Competitive Landscape 9. Company Profiles 1. Merck & Co., Inc. 2. Business Overview 3. Financial Overview 4. Business Strategies 6. Pfizer Inc. 7. Business Overview 8. Financial Overview 9. Business Strategies 11. Astellas Pharma Inc. 12. Business Overview 13. Financial Overview 14. Business Strategies 15. SCYNEXIS Inc.
List of Charts Figure 1: Site of Action of the Common Antifungal Agents in Generalized Fungal Cell Table 1: Competitive Profile of Antifungal Drug Classes Figure 2: Global Antifungal Therapeutics Market Size by Value, 2011-13 (US$ Billions) Figure 3: Global Antifungal Therapeutics Market Size by Value Forecasted, 2014E-19E (US$ Billions) Figure 4: Global Antifungal Therapeutics Market Share by Region (2012E) Figure 5: Global Antifungal Market by Organisms Causing Fungal Infection (2013) Figure 6: Global Antifungal Drug Class Market Share by Value (2013) Figure 7: Global Antifungal Drug Class Market Share by Volume (2013) Figure 8: Global Antifungal Drug Type Market Share by Value (2013) Figure 9: Global Antifungal Drug Type Market Share by Volume (2013) Figure 10: Structure of Some Common Polyene Antifungal Agents Table 2: Overview of Polyenes Market Figure 11: Global Antifungal Class Polyene Market Size, 2011-13 (US$ Millions) Figure 12: Global Antifungal Class Polyene Market Size Forecasted, 2014E-19E (US$ Millions) Figure 13: Structure of Some Common Azoles Antifungal Agents Table 3: Overview of Azoles Market Figure 14: Global Antifungal Agent Azole Market Size by Drugs, 2011-13 (US$ Millions) Figure 15: Global Antifungal Agent Azole Market Size Forecasted, 2014E-19E (US$ Millions) Figure 16: Global Azoles Market Share by Drug Types (2013) Figure 17: Structure of Some Common Echinocandins Antifungal Agents Table 4: Overview of Echinocandins Market
List of Charts Figure 20: Global Echinocandins Market Share by Drug Types (2013) Figure 21: Structure of Some Common Allylamines Antifungal Agents Table 5: Incidence of Serious Fungal Infections Table 6: Fungal Patients in the US and ROW Figure 22: Global Aging Population, 2005-13E (Millions) Figure 23: Growth in Candida glabrata Resistant Strains, 2001-10 Figure 24: Growth in Aspergillus fumigatus Resistant Strains, 2001-10 Table 7: Antifungal Drugs in Development for Systemic Candiasis and Aspergillosis Table 8: Competitive Landscape for Antifungal Agents Table 9: Antifungal Drug Sales by Indication Table 10: Global Sales of Select Antifungal Drugs Figure 25: Merck & Co., Inc. Revenue by Business Segment (2013) Figure 26: Merck & Co., Inc. Antifungal Drugs (Cancidas & Noxafil) Revenue, 2010-13 (US$ Millions) Figure 27: Pfizer Inc. Revenue by Business Segments (2013) Figure 28: Pfizer Inc. Antifungal Drugs (Vfend & Diflucan) Revenue, 2011-13 (US$ Millions) Figure 29: Astellas Pharma Inc. Sales by Geography (FY2013) Figure 30: Astellas Pharma Inc. Antifungal Drugs (Funguard/Mycamine & AmBisome) Revenue, FY2010-FY2013 (US$ Millions) Figure 31: SCYNEXIS, Inc. Revenue, FY2012-FY2013 (US$ Millions)
Title: Global Antifungal Market: Trends and Opportunities (2014-2019) Published: August 2014 Pages: 65 Price: US$ 800 (Single-User License) : US$ 1600 (Corporate License) For placing an order of the Report, please press the following link: http://www.daedal-research.com/global-antifungal-therapeutics-markettrends-and-opportunities-2014-2019
For more details please contact Mr. Rajeev Kumar: Tel: +91-120-4553017 (9.30 am - 6.30 pm) IST Mobile: +91-8743975789 (24 X7) Enquiries: info@daedal-research.com
Daedal Research
Daedal Research is a research and consulting firm specialized in providing research reports and customized business research and analysis. The research firm offers a blend of the best strategic consulting and market research solutions, which promise data rich, cost effective, and highly insightful analysis to help its clients with perfect answers to their